MARKETS
Markets

Zoetis Says 25% Of Simparica Trio-Treated Dogs Had Adult Heartworms vs. 75% On NexGard Plus In Drug-Resistant Heartworm Study

Oct 6, 2026 · 07:32 AM ET· updated 15h ago

Share
Why It Matters

Zoetis tested two dog medicines against tough heartworms. Simparica Trio worked better, so pet owners might trust it more.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.